Bosh sahifaQDEL • NASDAQ
add
Quidelortho Corp
39,05 $
Dastlabki sotuv:(0,00%)0,00
39,05 $
Yopilgan:4-mar, 0:30:44 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
39,99 $
Kunlik diapazon
39,04 $ - 40,99 $
Yillik diapazon
29,74 $ - 49,45 $
Bozor kapitalizatsiyasi
2,63 mlrd USD
Oʻrtacha hajm
865,02 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 707,80 mln | -4,69% |
Joriy xarajat | 279,10 mln | -0,71% |
Sof foyda | -178,40 mln | -2 648,57% |
Sof foyda marjasi | -25,20 | -2 780,85% |
Har bir ulushga tushum | 0,63 | -46,15% |
EBITDA | 153,60 mln | -28,99% |
Amaldagi soliq stavkasi | -26,61% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 99,60 mln | -40,54% |
Jami aktivlari | 6,42 mlrd | -24,99% |
Jami passivlari | 3,44 mlrd | -3,32% |
Umumiy kapital | 3,01 mlrd | — |
Tarqatilgan aksiyalar | 67,45 mln | — |
Narxi/balansdagi bahosi | 0,90 | — |
Aktivlardan daromad | 1,78% | — |
Kapitaldan daromad | 2,02% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -178,40 mln | -2 648,57% |
Operatsiyalardan naqd pul | 63,70 mln | -20,77% |
Sarmoyadan naqd pul | -37,90 mln | 31,22% |
Moliyadan naqd pul | -68,90 mln | -19,20% |
Naqd pulning sof oʻzgarishi | -45,50 mln | -49,67% |
Boʻsh pul | 223,64 mln | 29,61% |
Haqida
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
Tashkil etilgan
1979
Sayt
Xodimlar soni
6 600
